Mode
Text Size
Log in / Sign up
N/A N=14 Randomized Treatment

Multisensory Early Oral Administration of Human Milk in Preterm Infants

Infant Development · Stress

Enrolled (actual)
14
Serious AEs
0.0%
Results posted
Jan 2026
Primary outcome: Primary: Feasibility of Intervention — 0; 7 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Multisensory Early Oral Administration of Human Milk (M-MILK) (Other)
Age
Pediatric · 0+ yrs
Sex
All
Sponsor
Loyola University
Primary completion
Oct 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Feasibility of Intervention
0; 7
PRIMARY
Acceptability of Intervention
0; 5
PRIMARY
Retention
4; 7
PRIMARY
The Scarf Sign Cluster of the Neurobehavioral Assessment of the Preterm Infants Score
66.7; 66.7
PRIMARY
Variability in the Motor Development & Vigor Cluster of the Neurobehavioral Assessment of the Preterm Infants Score
53.1; 60.9
PRIMARY
Popliteal Angle Cluster of the Neurobehavioral Assessment of the Preterm Infants Score
16.7; 66.7
PRIMARY
Alertness and Orientation Cluster of the Neurobehavioral Assessment of the Preterm Infants Score
41.3; 82.5
PRIMARY
Irritability Cluster of the Neurobehavioral Assessment of the Preterm Infants Score
33.4; 33.4
PRIMARY
Quality of Cry Cluster of the Neurobehavioral Assessment of the Preterm Infants Score
0; 25
PRIMARY
Percent Sleep Cluster of the Neurobehavioral Assessment of the Preterm Infants Score
14.3; 14.3
PRIMARY
Early Feeding Skill Assessment Score
47.3; 49.6
SECONDARY
Parent Stressor Scale: NICU Score
2.4; 2.3
SECONDARY
Parent Discharge Readiness Score
231.0; 211.0
SECONDARY
Breastmilk Pumping Rate
1; 5
SECONDARY
Breastfeeding Rate
0; 1
SECONDARY
Maternal Edinburgh Postnatal Depression Scale Score
3.8; 4.8

Summary

The aims of this pilot are to determine the feasibility and acceptability of the Multisensory early oral administration of human milk (M-MILK) intervention, recruitment, retention, and obtain data for sample size estimation. This study will advance nursing science and practice because it will inform our R01 RCT to examine the efficacy of M-MILK to attenuate adverse effects of early life toxic stress in preterm infants.

Eligibility Criteria

Inclusion Criteria

  • born between 22 to 34 weeks gestational age and receiving mother's own milk and/or donor milk.

Exclusion Criteria

  • receiving only formula, oral cavity defects, gastrointestinal defects, chromosomal abnormalities, severe cardiac defects that require surgery, or intraventricular hemorrhage grade III or IV
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT06230848). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search